SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-186238"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-186238" > Diabetes mellitus a...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00009514naa a2200877 4500
001oai:DiVA.org:umu-186238
003SwePub
008210719s2021 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1862382 URI
0247 a https://doi.org/10.1136/rmdopen-2021-0017242 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Semb, Anne Greteu Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
2451 0a Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: An international audit
264 c 2021-07-08
264 1b BMJ Publishing Group Ltd,c 2021
338 a electronic2 rdacarrier
520 a Aim: The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention.Methods: The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014-2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM.Results: The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p<0.001). The proportion of patients with a diagnosis of hypertension, hyperlipidaemia and use of lipid-lowering or antihypertensive agents was higher among RA-DM than RAwoDM (p<0.001 for all). The majority of patients with ASCVD did not reach the lipid goal of low-density lipoprotein cholesterol <1.8 mmol/L. The lipid goal attainment was statistically and clinically significantly higher in RA-DM compared with RAwoDM both for patients with and without ASCVD. The systolic BP target of <140 mm Hg was reached by the majority of patients, and there were no statistically nor clinically significant differences in attainment of BP targets between RA-DM and RAwoDM.Conclusion: CVD preventive medication use and prevalence of ASCVD were higher in RA-DM than in RAwoDM, and lipid goals were also more frequently obtained in RA-DM. Lessons may be learnt from CVD prevention programmes in DM to clinically benefit patients with RA.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a arthritis
653 a atherosclerosis
653 a cardiovascular diseases
653 a hypertension
653 a lipids
653 a rheumatoid
7001 a Rollefstad, Silviau Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
7001 a Ikdahl, Eiriku Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
7001 a Wibetoe, Grundeu Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
7001 a Sexton, Josephu Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
7001 a Crowson, Cindyu Health Sciences Research, Mayo Clinic Rochester, MN, Rochester, United States4 aut
7001 a Van Riel, Pietu Rheumatology, Radboud University Nijmegen, Nijmegen, Netherlands4 aut
7001 a Kitas, Georgeu Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, United Kingdom4 aut
7001 a Graham, Ianu Cardiology, Trinity College Dublin, Dublin, Ireland4 aut
7001 a Rantapää-Dahlqvist, Solbrittu Umeå universitet,Reumatologi4 aut0 (Swepub:umu)sora0001
7001 a Karpouzas, George Athanasiosu Internal Medicine-Rheumatology, Harbor-UCLA Medical Center, CA, Torrance, United States4 aut
7001 a Myasoedova, Elenau Division of Rheumatology, Department of Internal Medicine, Mayo Clinic Rochester, MN, Rochester, United States4 aut
7001 a Gonzalez-Gay, Miguel A.u Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain4 aut
7001 a Sfikakis, Petros P.u First Department of Propedeutic Medicine, Medical School of University of Athens, Athens, Greece4 aut
7001 a Tektonidou, Maria G.G.u First Department of Propaedeutic Internal Medicine, University of Athens, Athens, Greece4 aut
7001 a Lazarini, Argyrou 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens School of Medicine, Athens, Greece4 aut
7001 a Vassilopoulos, Dimitriosu 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens School of Medicine, Athens, Greece4 aut
7001 a Kuriya, Bindeeu Medicine, Mount Sinai Hospital, ON, Toronto, Canada4 aut
7001 a Hitchon, Carolu Rheumatology, University of Manitoba, MN, Winnipeg, Canada4 aut
7001 a Stoenoiu, Maria Simonau Rheumatology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium4 aut
7001 a Durez, Patricku Rheumatology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium4 aut
7001 a Pascual-Ramos, Virginiau Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico4 aut
7001 a Galarza-Delgado, Dionicio Angelu Rheumatology, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Faggiano, Pompiliou Third Department of Internal Medicine, Department of Endocrinology and Metabolism, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Misra, Durga Prasannau Krajska Zdravotni A.s, Masaryk Hospital in Usti Nad Labem, Usti nad Labem, Czech Republic4 aut
7001 a Borg, Andrew A.u First Medical Faculty, Charles University, Praha, Czech Republic4 aut
7001 a Mu, Rongu Department of Internal Medicine III-Nephrology Rheumatology and Endocrinology, University Hospital Olomouc, Olomoucký, Olomouc, Czech Republic4 aut
7001 a Mirrakhimov, Erkin M.u Division of Rheumatology, 2nd Department of Internal Medicine-Gastroenterology, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Gheta, Dianeu Medicine, Tallaght University Hospital, Dublin, Ireland4 aut
7001 a Douglas, Karenu Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, United Kingdom4 aut
7001 a Agarwal, Vikasu Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Uttar Pradesh, Lucknow, India4 aut
7001 a Myasoedova, Svetlanau Rheumatology, Ivanovo State Medical Academy, Ivanovo, Ivanovskaa oblast', Russian Federation4 aut
7001 a Krougly, Levu Rheumatology, FSBi National Medical and Surgical Center Named after N i Pirogov, Ministry of Healthcare of the Russian Federation, Moskva, Russian Federation4 aut
7001 a Valentinovna Popkova, Tatianau Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moskva, Russian Federation4 aut
7001 a TuchyÅ ová, Alenau Rheumatology, Narodny Ustav Reumatickych Chorob, Piestany, Slovakia4 aut
7001 a Tomcik, Michalu Rheumatology, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Vrablik, Michalu Third Department of Internal Medicine, Department of Endocrinology and Metabolism, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Lastuvka, Jiriu Krajska Zdravotni A.s, Masaryk Hospital in Usti Nad Labem, Usti nad Labem, Czech Republic; First Medical Faculty, Charles University, Praha, Czech Republic4 aut
7001 a Horak, Pavelu Department of Internal Medicine III-Nephrology Rheumatology and Endocrinology, University Hospital Olomouc, Olomoucký, Olomouc, Czech Republic4 aut
7001 a Medkova, Helena Kasparu Division of Rheumatology, 2nd Department of Internal Medicine-Gastroenterology, Charles University, First Faculty of Medicine, Praha, Czech Republic4 aut
7001 a Kerola, Anne M.u Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 aut
7102 a Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norwayb Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway4 org
7730 t RMD Opend : BMJ Publishing Group Ltdg 7:2q 7:2x 2056-5933
8564 u https://doi.org/10.1136/rmdopen-2021-001724y Fulltext
8564 u https://umu.diva-portal.org/smash/get/diva2:1581058/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://rmdopen.bmj.com/content/rmdopen/7/2/e001724.full.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-186238
8564 8u https://doi.org/10.1136/rmdopen-2021-001724

Hitta via bibliotek

  • RMD Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy